BC
Broadwood Capital Portfolio holdings
AUM
$1.65B
1-Year Est. Return
54.78%
This Fund
S&P 500
1 Year Est. Return
+54.78%
AUM
$1.65B
AUM Growth
+$118M
(+7.7%)
Holding
13
Top Buys
No buys this quarter
Top Sells
| 1 | +$33.7M | |
| 2 | +$545K | |
| 3 | +$337K | |
| 4 |
Serina Therapeutics
SER
|
+$10.8K |
Sector Composition
| 1 | Consumer Staples | 33.59% |
| 2 | Industrials | 30.1% |
| 3 | Healthcare | 29.36% |
| 4 | Consumer Discretionary | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$78.9B
| $555M | 33.42% |
8,250,428
-5,000
|
|
||
2
Axon Enterprise
AXON
$38.4B
| $498M | 29.95% |
693,504
-760
|
|
||
3
STAAR Surgical
STAA
$935M
| $363M | 21.86% |
13,519,491
|
|
||
4
iShares Russell 2000 ETF
IWM
$74.2B
| $115M | 6.92% |
474,920
|
|
||
5
Lineage Cell Therapeutics
LCTX
$341M
| $83.8M | 5.04% |
49,560,992
|
|
||
|
IMDX
6
Insight Molecular Diagnostics
IMDX
$187M
| $37.9M | 2.28% |
11,410,100
|
|
||
|
7
Serina Therapeutics
SER
$34.7M
| $446K | 0.03% |
83,195
-2,024
|
|
||
|
OLO
8
DELISTED
Olo Inc
OLO
| – | – |
-3,782,821
|
|
||
9
American Airlines Group
AAL
$8.78B
| – | – |
0
|
|
||
10
Delta Air Lines
DAL
$43B
| – | – |
0
|
|
||
|
HBI
11
DELISTED
Hanesbrands
HBI
| – | – |
0
|
|
||
12
Southwest Airlines
LUV
$24.6B
| – | – |
0
|
|
||
13
United Airlines
UAL
$33.1B
| – | – |
0
|
|